Abstract
Duchenne muscular dystrophy (DMD) is an irreversible muscle disease characterized by a progressive loss of muscle function, decreased ambulation, and ultimately death as a result of cardiac or respiratory failure. DMD is caused by the lack of dystrophin, a protein that is important for membrane stability and signaling in excitable cells. Although vascular smooth muscle cells (VSMCs) dysfunction occurs in many pathological conditions, little is known about vascular smooth muscle function in DMD. We have previously shown that striated muscle cells, as well as neurons isolated from dystrophic (mdx) mice have higher intracellular Ca2+ ([Ca2+]i) and Na+ ([Na+]i) concentrations and decreased cell viability in comparison with wild type (Wt). Experiments were carried out in isolated VSMCs from mdx (a murine model of DMD) and congenic C57BL/10SnJ Wt mice. We found elevated [Ca2+]i and [Na+]i in VSMCs from mdx mice compared to Wt. Exposure to 1-oleoyl-2-acetyl-sn-glycerol (OAG), a TRPC3 and TRPC6 channel activator, induced a greater elevation of [Ca2+]i and [Na+]i in mdx than Wt VSMCs. The OAG induced increases in [Ca2+]i could be abolished by either removal of extracellular Ca2+ or by SAR7334, a blocker of TRPC3 and TRPC 6 channels in both genotypes. Mdx and Wt VSMCs were susceptible to muscle cell stretch-induced elevations of [Ca2+]i and [Na+]i which was completely inhibited by GsMTx-4, a mechanosensitive ion channel inhibitor. Western blots showed a significant upregulation of TRPC1 -3, -6 proteins in mdx VSMCs compare to age-matched Wt. The lack of dystrophin in mdx VSMCs produced a profound alteration of [Ca2+]i and [Na+]i homeostasis that appears to be mediated by TRPC channels. Moreover, we have been able to demonstrate pharmacologically that the enhanced stretch-induced elevation of intracellular [Ca2+] and concomitant cell damage in mdx VSMCs also appears to be mediated through TRPC1, -3 and -6 channel activation.
Keywords: Duchenne, calcium, TRPC, smooth muscle, mdx
Introduction
Duchenne muscular dystrophy (DMD) is an X-linked inherited neuromuscular disorder caused by mutations in the dystrophin gene (Hoffman et al., 1987). Dystrophin is localized in the plasmalemma of excitable cells connecting the cytoskeleton of the cell to the extracellular matrix (Ibraghimov-Beskrovnaya et al., 1992; Waite et al., 2012). While initial clinical manifestations of DMD are related to skeletal muscle weakness (Chakkalakal et al., 2005), the development of dilated cardiomyopathy occurs occasioning heart failure and death (Nigro et al., 1990) and a non-progressive cognitive impairment has been observed in DMD patients (Bresolin et al., 1994; Anderson et al., 2002). Disturbance of intracellular [Ca2+] has been reported in skeletal muscle from DMD patients (Lopez et al., 1987) and mdx mice (Turner et al., 1988; Altamirano et al., 2013, 2014), in cardiac cells from mdx mice (Mijares et al., 2014) and in cortical and hippocampal neurons isolated from mdx mice (Lopez et al., 2016).
Although X-linked neuromuscular pathologies have been extensively studied in striated muscle, the implications of lack of dystrophin in smooth muscle in patients with DMD and mdx mice have not been adequately studied. Studies on mdx dystrophic gastric and intestinal smooth muscle cells have revealed impaired nitrergic relaxation and an increase in spontaneous tone, which have been attributed to the impairment of intracellular Ca2+ homeostasis (Mule et al., 1999; Baccari et al., 2000; Mule and Serio, 2001). In addition, in DMD patients, dysfunction in small airways (Begin et al., 1980), constipation (Nowak et al., 1982), gastric dilatation, intestinal pseudo-obstructions and acute gastric dilatation (Leon et al., 1986; Barohn et al., 1988; Jaffe et al., 1990) have been described. Furthermore, endothelial cell damage, platelet adhesion, and aggregation in small blood vessels have been observed in DMD patients (Miike et al., 1987). However, the functional implications of the lack of dystrophin in vascular smooth muscle cells (VSMCs) are mostly unknown.
In the current study, we show for the first time that dystrophin deficiency of VSMCs leads to dysfunctional regulation of [Ca2+]i and [Na+]i, which appears to be mediated by an influx of these ions through the transient receptor potential canonical (TRPC) channels. Furthermore, mechanical stretch elicited a further elevation of [Ca2+]i in VSMCs from mdx compared to Wt, which was inhibited by the removal of extracellular calcium and by TRPC channel blockade.
Materials and Methods
Animal Model
Wt (C57BL/10SnJ) and mdx (CS7BL/10ScSn-mdx) male (6 months old) mice were obtained from breeding colonies at the Mount Sinai Medical Center, from founders initially obtained from the Jackson Laboratory (Bar Harbor, ME). All protocols used in the study were performed following the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the institution (IACUC Protocol #19090).
Primary Culture of VSMC
Mdx and their Wt non-dystrophic littermates were euthanized using CO2 or cervical dislocation. VSMCs were isolated using a modification of a previously described method (Ray et al., 2001). In brief, the aorta was dissected from its origin at the left ventricle to the iliac bifurcation, and the vessel was cut and placed in Hank’s Balanced Salt Solution (HBSS) (Thermo Fisher Scientific, FL, United States). Using a dissecting microscope, the fat tissue and the adventitia were removed; then, the aorta was irrigated with HBSS plus 2.5 μg/mL Fungizone (Thermo Fisher Scientific, FL, United States). The vessel was open longitudinally, and with sterile cotton swabbed, the endothelial layer of cells was gently removed and then cut into small segments (around 4 mm2 each). The aorta segments were incubated in HBSS containing 1 mg/ml collagenase type 2 (Worthington Biochemical Corporation, NJ, United States) for 30 min. Then, the solution containing collagenase type 2 was replaced with a solution containing 1 mg/ml collagenase type 2 and 0.5 mg/ml elastase (Worthington Biochemical Corporation, NJ, United States). After the second digestion step, the remaining tissue was mechanically dissociated in the dish by flushing through a series of decreasing size fire-polished pipettes. Fresh HBSS was then added to stop the enzymatic digestion, and the cell suspension was centrifugated at 600 × g. The cell pellet was resuspended and centrifugated again at 600 × g and then transferred to a Matrigel-coated 24-well cell culture plate containing smooth muscle cell growth medium (SGM-2, Lonza, GA, United States). Isolated VSMC were cultured in a humidified atmosphere (37°C) and for 7–10 days after platting before experimentation.
Assessment of VSMC Functionality
The following criteria were used to judge the functionality of VSMCs: (i) no cell shortening was observed when they perfused with the Ca2+ containing Ringer solution (1.8 mM Ca2+) and (ii) they contracted in response to electrical stimuli (1 ms square pulse duration, ∼1.5 × threshold voltage).
Measurements of Resting [Ca2+]i and [Na+]i
Double-barreled Ca2+ and Na+ selective microelectrodes were prepared as described previously (Eltit et al., 2013). Single smooth muscle cells were impaled with either a Ca2+ – or Na+-selective double-barreled microelectrode, and their potentials were recorded via a high-impedance amplifier (WPI Duo 773 electrometer; World Precision Instruments, FL, United States). Criteria for successful impalement of single muscle cells included an (i) abrupt drop to a steady level of Vm more negative than −55 mV, (ii) a recording stable for both potentials (Vm and Ca potential) for at least 60 s and (iii) an quick return to baseline on the exit of the microelectrodes from the cell. The specific Ca2 + potential (VCae) or Na+ potential (VNae) was obtained by subtracting the VCa potential or VNa from the 3 M KCl microelectrode potential (Vm); Vm, and the specific Ca2+- Na+ potentials were stored in a computer for future analysis.
Muscle Mechanical Stretch
VSMCs were seeded on flexible-bottomed culture plates coated with poly-L-lysine (Flexcell International Corp., NC, United States). After 48 h to allow for cell attachment and spreading, Wt and mdx VSMCs were bathing with Ringer solution and then subjected to mechanical stretch elongation of 30 cycles/min (0.5 Hz), 20% elongation using a Flexcell FX 5000 tension system for 5 min. After the cyclic stretch, to estimate cell damage, the medium was collected for the determination of lactate dehydrogenase (LDH) activity (released by VSMCs) using the LDH kit from Sigma-Aldrich (St. Louis, MO, United States) according to the manufacturer’s instructions. Parallel series of Flex culture plates not subjected to stretching served as controls. At the time of collection of the medium for LDH determination, [Ca2+]i or [Na+]i was measured in the stretched VSMCs using ion-selective microelectrodes.
Western Blot Analysis
Mdx and Wt anesthetized mice were euthanized using CO2. The aorta was dissected as described above (Primary culture of VSMC). Aortic total protein extraction was performed using a modified Millipore enzyme buffer with added 0.5% Triton-X-100 for 1 h digestion and lysis step. After proteins transfer from the gel, we spliced the membrane horizontally according to the molecular weight of proteins of interest. Then, individual membrane strips were incubated with the primary anti-TRPC1, TRPC3, TRPC6, and dystrophin antibodies (Uryash et al., 2015). The corresponding protein size was determined based on the protein standard marker. The levels of target protein(s) were normalized to loading control using the housekeeper protein β-actin.
Solutions
The normal Ringer’s solution contained the following (in mM): 135 NaCl, 5 KCl, 1.8 CaCl2, 1 MgCl2, 5 glucose, 3.6 NaHCO3 (pH 7.4). In all experiments, Wt and mdx VSMCs were perfused and equilibrated with the Ringer’s solution aerated with a mixture of 95% O2 and 5% CO2 at 37°C. For the Ca2+ free solution CaCl2 was omitted and 2 mM MgCl2 and 1 mM EGTA were added in its place. 1-oleoyl-2-acetyl-sn-glycerol (OAG) (100 μM) a TRPC3, and TRPC6 channel activator, SAR7334 (0.1 and 1 μM) a TRPC3 and TRPC6 channel blocker, GsMTx4 (5 μM) a specific mechanosensitive channel inhibitor, nifedipine (10 μM) a selective voltage-gated Ca2+ channel blocker solutions were prepared from stock solutions.
Statistical Analysis
All values are reported as mean ± SD. Student’s t-test or analysis of variance (1-way ANOVA and Tukey’s post hoc tests were used to determine significance. p < 0.05 was considered statistically significant. nmice: number of mice used experimentally, ncell: represents the number of successful measurements carried out.
Results
[Ca2+]i and [Na+]i Dyshomeostasis in mdx Vascular Smooth Cells
Striated muscle cells from DMD patients and mdx mice (Lopez et al., 1987; Altamirano et al., 2013, 2014; Mijares et al., 2014) show elevated intracellular Ca2+ and Na+. Therefore, intracellular [Ca2+] and [Na+] were measured in VSMCs isolated from Wt and mdx mice using double-barreled ion-specific microelectrodes. [Ca2+]i was elevated in mdx VSMCs (266 ± 27 nM, n = 45) compared to that observed in Wt cells (121 ± 3 nM, n = 41), (p < 0.001) (Figure 1). Similarly, [Na+]i was higher in mdx VSMCs (14 ± 1.2 mM n = 25) than observed in Wt cells (8 ± 0.1 mM n = 25) (p < 0.001) (Figure 1).
OAG a TRPC3 and TRPC6 Activator, Induced Elevation of [Ca2+]i and [Na+]i in VSMCs
To directly investigate the effect of diacylglycerol (DAG) on [Ca2+]i and [Na+]i in smooth muscle cells, VSMCs were exposed to the DAG analog 1-oleoyl-2-acetyl-sn-glycerol (OAG) which activates TRPC3 and TRPC6 channels (Hofmann et al., 1999). Incubation in OAG (100 μM) for 10 min produces an elevation of [Ca2+]i and [Na+]i in both genotypes. Figures 2A–D show representative measurements of the resting membrane potential (Vm) and [Ca2+]i from Wt and mdx VSMCs before and after exposure to OAG. In Wt VSMCs OAG provoked an increase of [Ca2+]i by 46%, from 121 ± 3 nM, n = 22, to 177 ± 19 nM, n = 25 (p < 0.001), and in mdx VSMCs by 73%, from 271 ± 29 nM, n = 25, to 470 ± 55 nM, n = 27 (p < 0.001) (Figure 3A). [Na+]i was also significantly elevated in Wt by 25% and in mdx VSMC by 46% upon incubation in OAG (Figure 3B). We examined the possible involvement of the voltage-gated Ca2+ channels in the OAG-induced elevation of [Ca2+]i by pretreating cultured VSMCs with nifedipine 10 μM, a specific voltage-gated Ca2+ channel blocker. Nifedipine had no significant effects on OAG-induced elevation of [Ca2+]i in either Wt or mdx VSMCs (Supplementary Figure S1).
Removal of Extracellular Ca2+ Reduced [Ca2+]i and Prevented OAG-Induced Elevation of [Ca2+]i
To establish the impact of extracellular Ca2+ ([Ca2+]e) on OAG-induced elevation of [Ca2+]i, Wt and mdx VSMCs were incubated for 5 min in Ca2+-free solution before OAG (100 μM) treatment. Exposure to reduced [Ca2+]e significantly lowered [Ca2+]i in Wt and mdx VSMCs but had a greater effect in mdx (−49%, from 271 ± 24, n = 15 to 138 ± 11, n = 18, p < 0.001) than in Wt (−18%, from 122 ± 3 nM, n = 15 to 100 ± 5 nM, n = 17, p < 0.001) VSMCs (Figure 4). In the absence of [Ca2+]e, the previously observed rise in [Ca2+]i elicited by OAG in Ca2+ replete buffer was completely inhibited in both Wt and mdx VSMCs (Figure 3). In addition to the decrease in [Ca2+]i, incubation in Ca2+-free solution leads to a reversible depolarization of cell membrane potential in both genotypes of about 4–6 mV despite the presence of 2 mM Mg2+ (Supplementary Figure S2).
SAR7334 Reduced [Ca2+]i and Abolished the Increases of [Ca2+]i and [Na+]i Elicited by OAG
To gain insight into molecular mechanisms resulting in [Ca2+]i elevation upon exposure to OAG, we measured [Ca2+]i in Wt and mdx VSMCs before and after incubation with SAR7334 which is a blocker of TRPC6 and TRPC3 channels (Maier et al., 2015), and then again after exposure to OAG (100 μM). Pretreatment with SAR7334 significantly lowered [Ca2+]i in dose-dependent manner in both genotypes. Pretreatment with 0.1 μM SAR7334, a concentration that block mostly TRPC6 channels (Maier et al., 2015) reduced [Ca2+]i in Wt by 6% and in mdx VSMCs by18% (Figure 5A). Preincubation with SAR7334 (1 μM) that blocks TRPC3 and 6 channels (Maier et al., 2015) provoked further reduction of [Ca2+]i in Wt (15%) and mdx VSMCs (50%) (Figure 5B). The Figure 6 shows representative records of the effects of SAR7334 on [Ca2+]i in Wt VSMCs (Figure 6B), and mdx VSMCs (Figure 6D). In addition, SAR7334 1 μM also reduced [Na+]i in Wt (13%) and in mdx VSMCs (35%) (Figure 5C) and prevented any significant increase in [Ca2+]i and [Na+]i upon exposure to OAG in both genotypes (Figures 5B,C).
Cyclic Stretch Provokes Larger Increase of [Ca2+]i and [Na+]i in mdx VSMCs
Stretching smooth muscle cells has previously been shown to increase [Ca2+]i (Zou et al., 2002; Ducret et al., 2010). Numerous members of the TRPC channel family, especially TRPC1, TRPC3, and TRPC6 are considered to be mechanosensitive channels (Friedrich et al., 2012; Takahashi et al., 2013) and are therefore possible candidates for this increase. In our VSMC stretch experiments [Ca2+]i and [Na+]i increased in both genotypes; however, the magnitude of the increases in Ca2+ and Na+ were greater in mdx than Wt. In Wt VSMCs [Ca2+]i was elevated by 39% from 121 ± 3 nM, n = 25 to 169 ± 18 nM, n = 23 (p < 0.001) (Figure 7A) and [Na+]i by 31% from to 8 ± 0.1 mM, n = 10 to 11 ± 1 mM, n = 10 (p < 0.001) (Figures 7B). In mdx VSMCs [Ca2+]i was elevated by 69% from 285 ± 25 nM, n = 25 to 482 ± 37 nM, n = 20 (p < 0.001) (Figure 7A) and [Na+]i by 43% from to 14 ± 1.2 mM, n = 19 to 20 ± 1.8 mM, n = 12 (p < 0.001) (Figure 7B). To test whether the elevation of [Ca2+]i associated with stretch was mediated by Ca2+ influx through sarcolemma Ca2+ channels, extracellular Ca2+ was removed and 2 mM MgCl2 and 1 mM EGTA were added to the bathing supernatant (see section “Materials and Methods”). Under these conditions the increase in [Ca2+]i in response to stretch was abolished in both Wt and mdx VSMCs (Figure 8A). Re-addition of extracellular Ca2+ before repeating the stretch protocol allowed recovery of the increase in both genotypes. These results suggest that a Ca2+ influx was involved in the elevation of [Ca2+]i upon the mechanical stretch. To further dissect the mechanism involved in the stretch-induced elevation of [Ca2+]i in VSMCs we tested the effect of GsMTx-4 (5 μM), which is known to inhibit mechanosensitive channels (Spassova et al., 2006; Bowman et al., 2007). GsMTx-4 completely inhibited the stretch-induced increases of [Ca2+]i in both genotypes (Figure 8B). Additionally, we examined whether the stretch-induced elevation of [Ca2+]i was mediated via L-type voltage-gated Ca2+ channels by incubating the VSMCs with the Ca2+ channel blocker nifedipine (10 μM). The stretch-induced increase in [Ca2+] was not modified by nifedipine in either genotype (Supplementary Figure S3).
Cyclic Stretch Provokes Cell Damage in mdx VSMCs
Resting LDH activity in the supernatant from non-stretched mdx VSMCs (a marker of cell damage) was 35% greater than in the supernatant from Wt VSMCs (Figure 9). Muscle stretching increased LDH activity in both genotypes; however, the increase was more significant in mdx than Wt VSMCs (41% in Wt vs. 90% in mdx VSMCs) (Figure 9).
Measurements of Protein Expression
To determine whether the elevation of [Ca2+]i and [Na+]i and enhanced response to OAG observed in dystrophic VSMs was associated with changes in TRPC protein in the membrane, the expression of TRPC1, -3 and -6 were measured using Western blot analysis. Analysis of these blots demonstrated that TRPC1, TRPC3, and TRPC6 were significantly upregulated in VSMCs from mdx compared to Wt mice (Figures 10A,B and Supplementary Figure S4).
Discussion
To the best of our knowledge, this is the first comprehensive study of [Ca2+]i and [Na+]i dysregulation in mdx VSMCs. The main findings in the present study are the following: (i) quiescent VSMCs isolated from mdx mice have [Ca2+]i and [Na+]i overload; (ii) the increase in [Ca2+]i and [Na+]i induced by exposure to OAG was greater in mdx than Wt VSMCs; (iii) Removal of extracellular Ca2+ or blockade of TRPC3 and -6 channels abolished the increases of [Ca2+]i and [Na+]i elicited by OAG; (iv) Muscle stretch-induced elevation of [Ca2+]i, and [Na+]i was significantly higher in mdx than Wt VSMCs and removal of extracellular Ca2+ or exposure to mechanosensitive channel blockers inhibited the increase in [Ca2+]i linked to mechanical stretch in both mdx and Wt VSMCs; (v) Baseline and stretch-induced LDH leak was significantly higher in mdx than Wt VSMCs; (vi) Expression of TRPC1, -3, and -6 proteins was upregulated in mdx compared to Wt VSMCs.
Duchenne muscular dystrophy is a lethal muscle disease characterized by the absence of dystrophin, which leads to progressive membrane injury and subsequent changes in intracellular Ca2+ homeostasis and cellular dead (Ervasti et al., 1990). Dystrophin is the major component dystrophin-glycoprotein complex, which allows the interaction between the cytoskeleton and the and extracellular matrix (Ervasti and Campbell, 1993). Dystrophin is also present in the smooth muscle, playing a similar role than in skeletal muscle (North et al., 1993; Sharma et al., 2008). Deficiency of dystrophin in striated muscle cells results in alterations intracellular ion dyshomeostasis and muscle degeneration (Lopez et al., 1987; Danialou et al., 2001; Allen and Whitehead, 2011; Altamirano et al., 2012, 2014). In smooth muscle, the lack of dystrophin has been related with different alterations in the respiratory, gastrointestinal tract and the vascular bed (Miike et al., 1987; Barohn et al., 1988; Jaffe et al., 1990; Sun, 2015; Brown et al., 2018).
Intracellular calcium plays an essential role under physiological conditions to regulate many different processes in VSMCs (Berridge et al., 2003; Huang et al., 2018). Quiescent and healthy excitable cells maintain an [Ca2+]i in the vicinity of 100–120 nM versus an extracellular [Ca2+] of 1.8 mM (Lopez et al., 1983; Mijares et al., 2014; Lopez et al., 2018). The activity of membrane ion channels, plasma membrane ATP-dependent Ca2+-pump, Na+/Ca2+ exchangers, and an endoplasmic reticulum Ca2+ ATPase preserve the concentration gradient (Karaki et al., 1997). Our data show that quiescent VSMCs isolated from mdx mice have an intracellular Ca2+ and Na+ overload compared with non-dystrophic Wt VSMCs. A substantial increase in [Ca2+]i has been reported in intact skeletal muscle from DMD patients and an altered intracellular Ca2+ and Na+ homeostasis has been observed in the skeletal and cardiac muscle cells from mdx mice (Altamirano et al., 2014; Lopez et al., 2017, 2018). Chronic elevation in [Ca2+]i may activate hydrolytic enzymes (proteases, nucleases, and lipases), and subsequently compromise energy production, intracellular ion regulation, ROS production and ultimately result in cell death (Nicotera and Orrenius, 1998; Ascah et al., 2011; Altamirano et al., 2013, 2014; Lopez et al., 2017). Prevention of chronic elevation of [Ca2+]i may exert a myoprotective effect on mdx VSMCs precluding cell death.
The TRPC channels are expressed in vascular smooth muscle vessels playing diverse physiological cellular responses (Yip et al., 2004; Inoue et al., 2006). We have demonstrated that application of OAG, a membrane-permeable diacylglycerol analog which activates TRPC3 and TRPC6 channels (Hofmann et al., 1999; Liu et al., 2005) produced a robust elevation of [Ca2+]i and [Na+]i in Wt and mdx, however, the increment was more significant in mdx than Wt VSMCs. Western blots showed a significant upregulation of TRPC1 -3, -6 proteins in mdx VSMCs compare to age-matched Wt, which probably contribute to the observed intracellular Ca2+, and Na+ overload and also to the greater responsiveness to OAG found in mdx VSMCs.
Ca2+-free solution inhibited the observed rise in [Ca2+]i induced by OAG and induced a reversible depolarization of cell membrane potential. The effect of removing extracellular Ca2+ on resting membrane potential in smooth muscle has been previously reported by other groups (Bulbring and Tomita, 1970; Kuriyama and Tomita, 1970). Furthermore, the incubation of VSCMs with SAR7334, a TRPC3 and TRPC6 blocker (Maier et al., 2015), reduced [Ca2+]i in a dose-dependent manner and also blocked the increases in [Ca2+]i and [Na+]i elicited by OAG in both Wt and mdx VSMCs. Based on SAR7334 pharmacological dose blocking effect on TRPC3 and TRPC6 channels (Maier et al., 2015), we can speculate that the contribution of TRPC3 channels to the VSMCs intracellular Ca2+ dyshomeostasis is more significant than TRPC6 channels. The increase of [Ca2+]i induced by OAG was not affected by the Ca2+ channel inhibitor nifedipine, which suggests that the activation of L-type Ca2+ channels is not part of the mechanism by which OAG induced elevation of [Ca2+]i and [Na+]i in VSMCs. Dysregulation of TRPC channels has been associated with diverse vascular pathologies (Mandegar et al., 2002; Yu et al., 2004; Kumar et al., 2006) which could explain, at least in part, the severe pulmonary and systemic hypertension reported in children and adolescents suffering from DMD (Yotsukura et al., 1988; Braat et al., 2015).
Previous studies have demonstrated that VSCM stretch induces elevation of [Ca2+]i (Zou et al., 2002; Ducret et al., 2010). TRPC channels, especially TRPC1, TRPC3, and TRPC6, are considered as mechanosensitive channels (Friedrich et al., 2012; Takahashi et al., 2013). Furthermore, the Gq/11 protein has been recognized as mechanosensors involve in the myogenic vasoconstriction in VSMCs of small resistance arteries (Mederos et al., 2008, 2016). Gq/11-coupled receptors appear to be linked to the TRPC channels provoking the activation of TRPC channels in a G protein-dependent manner (Mederos et al., 2008). Here, we have shown evidence that a Ca2+ influx pathway activated by mechanosensors in VSMCs appears to be mediated by canonical cationic channel, which seems to be more critical in mdx VSMCs than Wt. Extracellular Ca2+ influx mediated by the voltage-dependent L-type Ca2+ channels has been suggested to intervene in VSMC stretch-mediated activation (Murase et al., 2001; Park et al., 2003; Ito et al., 2008). However, the fact that nifedipine did not inhibit stretch-induced [Ca2+]i elevation does not support this hypothesis.
Basal LDH activity in the extracellular medium was higher in the supernatant from mdx compared to Wt VSMCs, which is consistent with the idea that the absence of dystrophin leads to chronic injury due to a lack of structural support at the sarcolemma. Besides, stretching further increased extracellular LDH activity, an indicator that this muscle stretch yielded some degree of cell injury in both genotypes. However, because the increase was higher in mdx than Wt, these data support the view that the lack of dystrophin makes VSCMs more sensitive to contraction-induced damage (Petrof et al., 1993; Grady et al., 1997; Brooks, 1998). The intracellular Ca2+ elevation after VSMCs stretch was suppressed entirely in both genotypes by removal of extracellular Ca2+ or GsMTx-4, indicating that this event is mediated by Ca2+ influx from the extracellular side which appears to be through a GsMTx-4 sensitive pathway.
Study Limitations
Despite the novelty of our study, some limitations should be acknowledged. First, we used a pharmacological approach to characterize the involvement of TRPC channels in the dysregulation of intracellular Ca2+ observed in VSMCs from mdx mice, and we did not study the functional aspects of TRPC channels. Secondly, we did not carry out experiments in which TRPC1, -3, and -6 channels were individually or collectively downregulated using siRNA. Therefore, we were unable to assess whether decreasing TRPC channel expression rescues or improves intracellular Ca2+ regulation in mdx VSMCs.
Conclusion
This study provides direct evidence of anomalous regulation of resting intracellular Ca2+ and Na+ in VSMCs from mdx mice. The imbalance of [Ca2+]i and [Na+]i appears to be mediated mostly through TRPC channels since their pharmacological blocking activity markedly protected mdx VSMCs (Figure 11). Further, we have demonstrated the presence of an abnormal stretch-induced elevation of [Ca2+]i in mdx VSMCs, which also appears to be mediated by TRPC channels. The originality of our paper stands in revealing the relevance of TRPC channels in the pathology of VSMCs in mdx mice. TRPC channels could be promising targets to help manage symptoms and slow the progression of this devastating disease.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
Ethics Statement
All protocols used in the study were performed following the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and approved by the IACUC of Mount Sinai Medical.
Author Contributions
JL and JA contributed to the conception and design of the study. JL, AU, GF, and EE performed the experiments. All authors contributed to the manuscript revision, read and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
We are grateful to Dr. M. Sackner and Dr. P. D. Allen for all the valuable comments.
Footnotes
Funding. This work was supported by the AFM-Téléthon-France (Grant No. 21543).
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphys.2020.00126/full#supplementary-material
References
- Allen D. G., Whitehead N. P. (2011). Duchenne muscular dystrophy–what causes the increased membrane permeability in skeletal muscle? Int. J. Biochem. Cell Biol. 43 290–294. 10.1016/j.biocel.2010.11.005 [DOI] [PubMed] [Google Scholar]
- Altamirano F., Lopez J. R., Henriquez C., Molinski T., Allen P. D., Jaimovich E. (2012). Increased resting intracellular calcium modulates NF-kappaB-dependent inducible nitric-oxide synthase gene expression in dystrophic mdx skeletal myotubes. J. Biol. Chem. 287 20876–20887. 10.1074/jbc.M112.344929 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altamirano F., Perez C. F., Liu M., Widrick J., Barton E. R., Allen P. D., et al. (2014). Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice. PLoS One 9:e106590. 10.1371/journal.pone.0106590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Altamirano F., Valladares D., Henriquez-Olguin C., Casas M., Lopez J. R., Allen P. D., et al. (2013). Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice. PLoS One 8:e81222. 10.1371/journal.pone.0081222 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson J. L., Head S. I., Rae C., Morley J. W. (2002). Brain function in Duchenne muscular dystrophy. Brain 125 4–13. 10.1093/brain/awf012 [DOI] [PubMed] [Google Scholar]
- Ascah A., Khairallah M., Daussin F., Bourcier-Lucas C., Godin R., Allen B. G., et al. (2011). Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. Am. J. Physiol. Heart Circ Physiol. 300 H144–H153. 10.1152/ajpheart.00522.2010 [DOI] [PubMed] [Google Scholar]
- Baccari M. C., Romagnani P., Calamai F. (2000). Impaired nitrergic relaxations in the gastric fundus of dystrophic (mdx) mice. Neurosci. Lett. 282 105–108. 10.1016/s0304-3940(00)00879-x [DOI] [PubMed] [Google Scholar]
- Barohn R. J., Levine E. J., Olson J. O., Mendell J. R. (1988). Gastric hypomotility in Duchenne’s muscular dystrophy. N. Engl. J. Med. 319 15–18. [DOI] [PubMed] [Google Scholar]
- Begin R., Bureau M. A., Lupien L., Lemieux B. (1980). Control of breathing in Duchenne’s muscular dystrophy. Am. J. Med. 69 227–234. [DOI] [PubMed] [Google Scholar]
- Berridge M. J., Bootman M. D., Roderick H. L. (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell. Biol. 4 517–529. 10.1038/nrm1155 [DOI] [PubMed] [Google Scholar]
- Bowman C. L., Gottlieb P. A., Suchyna T. M., Murphy Y. K., Sachs F. (2007). Mechanosensitive ion channels and the peptide inhibitor GsMTx-4: history, properties, mechanisms and pharmacology. Toxicon 49 249–270. 10.1016/j.toxicon.2006.09.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Braat E., Hoste L., De Waele L., Gheysens O., Vermeersch P., Goffin K., et al. (2015). Renal function in children and adolescents with Duchenne muscular dystrophy. Neuromuscul. Disord. 25 381–387. 10.1016/j.nmd.2015.01.005 [DOI] [PubMed] [Google Scholar]
- Bresolin N., Castelli E., Comi G. P., Felisari G., Bardoni A., Perani D., et al. (1994). Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul. Disord. 4 359–369. [DOI] [PubMed] [Google Scholar]
- Brooks S. V. (1998). Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J. Muscle Res. Cell Motil. 19 179–187. [DOI] [PubMed] [Google Scholar]
- Brown I. A. M., Diederich L., Good M. E., Delalio L. J., Murphy S. A., Cortese-Krott M. M., et al. (2018). Vascular smooth muscle remodeling in conductive and resistance arteries in hypertension. Arterioscler. Thromb. Vasc. Biol. 38 1969–1985. 10.1161/ATVBAHA.118.311229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bulbring E., Tomita T. (1970). Effects of Ca removal on the smooth muscle of the guinea-pig taenia coli. J. Physiol. 210 217–232. 10.1113/jphysiol.1970.sp009205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chakkalakal J. V., Thompson J., Parks R. J., Jasmin B. J. (2005). Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies. FASEB J. 19 880–891. 10.1096/fj.04-1956rev [DOI] [PubMed] [Google Scholar]
- Danialou G., Comtois A. S., Dudley R., Karpati G., Vincent G., Des Rosiers C., et al. (2001). Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 15 1655–1657. 10.1096/fj.01-0030fje [DOI] [PubMed] [Google Scholar]
- Ducret T., El Arrouchi J., Courtois A., Quignard J. F., Marthan R., Savineau J. P. (2010). Stretch-activated channels in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats. Cell Calcium 48 251–259. 10.1016/j.ceca.2010.09.011 [DOI] [PubMed] [Google Scholar]
- Eltit J. M., Ding X., Pessah I. N., Allen P. D., Lopez J. R. (2013). Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia. FASEB J. 27 991–1000. 10.1096/fj.12-218354 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ervasti J. M., Campbell K. P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122 809–823. 10.1083/jcb.122.4.809 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ervasti J. M., Ohlendieck K., Kahl S. D., Gaver M. G., Campbell K. P. (1990). Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345 315–319. 10.1038/345315a0 [DOI] [PubMed] [Google Scholar]
- Friedrich O., Wagner S., Battle A. R., Schurmann S., Martinac B. (2012). Mechano-regulation of the beating heart at the cellular level–mechanosensitive channels in normal and diseased heart. Prog. Biophys. Mol. Biol. 110 226–238. 10.1016/j.pbiomolbio.2012.08.009 [DOI] [PubMed] [Google Scholar]
- Grady R. M., Teng H., Nichol M. C., Cunningham J. C., Wilkinson R. S., Sanes J. R. (1997). Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90 729–738. 10.1016/s0092-8674(00)80533-4 [DOI] [PubMed] [Google Scholar]
- Hoffman E. P., Brown R. H., Jr., Kunkel L. M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 919–928. 10.1016/0092-8674(87)90579-4 [DOI] [PubMed] [Google Scholar]
- Hofmann T., Obukhov A. G., Schaefer M., Harteneck C., Gudermann T., Schultz G. (1999). Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397 259–263. 10.1038/16711 [DOI] [PubMed] [Google Scholar]
- Huang H., Sun Z., Hill M. A., Meininger G. A. (2018). A calcium mediated mechanism coordinating vascular smooth muscle cell adhesion during KCl activation. Front. Physiol. 9:1810. 10.3389/fphys.2018.01810 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ibraghimov-Beskrovnaya O., Ervasti J. M., Leveille C. J., Slaughter C. A., Sernett S. W., Campbell K. P. (1992). Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 696–702. 10.1038/355696a0 [DOI] [PubMed] [Google Scholar]
- Inoue R., Jensen L. J., Shi J., Morita H., Nishida M., Honda A., et al. (2006). Transient receptor potential channels in cardiovascular function and disease. Circ. Res. 99 119–131. 10.1161/01.res.0000233356.10630.8a [DOI] [PubMed] [Google Scholar]
- Ito S., Kume H., Naruse K., Kondo M., Takeda N., Iwata S., et al. (2008). A novel Ca2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 38 407–413. 10.1165/rcmb.2007-0259oc [DOI] [PubMed] [Google Scholar]
- Jaffe K. M., Mcdonald C. M., Ingman E., Haas J. (1990). Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. Arch. Phys. Med. Rehabil. 71 742–744. [PubMed] [Google Scholar]
- Karaki H., Ozaki H., Hori M., Mitsui-Saito M., Amano K., Harada K., et al. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49 157–230. [PubMed] [Google Scholar]
- Kumar B., Dreja K., Shah S. S., Cheong A., Xu S. Z., Sukumar P., et al. (2006). Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ. Res. 98 557–563. 10.1161/01.res.0000204724.29685.db [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuriyama H., Tomita T. (1970). The action potential in the smooth muscle of the guinea pig taenia coli and ureter studied by the double sucrose-gap method. J. Gen. Physiol. 55 147–162. 10.1085/jgp.55.2.147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leon S.H., Schuffler M. D., Kettler M., Rohrmann Ca. (1986). Chronic intestinal pseudoobstruction as a complication of Duchenne’s muscular dystrophy. Gastroenterology 90 435–459. [DOI] [PubMed] [Google Scholar]
- Liu X., Bandyopadhyay B. C., Singh B. B., Groschner K., Ambudkar I. S. (2005). Molecular analysis of a store-operated and 2-acetyl-sn-glycerol-sensitive non-selective cation channel. Heteromeric assembly of TRPC1-TRPC3. J. Biol. Chem. 280 21600–21606. 10.1074/jbc.c400492200 [DOI] [PubMed] [Google Scholar]
- Lopez J. R., Alamo L., Caputo C., Dipolo R., Vergara S. (1983). Determination of ionic calcium in frog skeletal muscle fibers. Biophys. J. 43 1–4. 10.1016/s0006-3495(83)84316-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lopez J. R., Briceno L. E., Sanchez V., Horvart D. (1987). Myoplasmic (Ca2+) in Duchenne muscular dystrophy patients. Acta Cient. Venez. 38 503–504. [PubMed] [Google Scholar]
- Lopez J. R., Kolster J., Uryash A., Esteve E., Altamirano F., Adams J. A. (2016). Dysregulation of intracellular Ca2+ in dystrophic cortical and hippocampal neurons. Mol. Neurobiol. 55 603–618. 10.1007/s12035-016-0311-7 [DOI] [PubMed] [Google Scholar]
- Lopez J. R., Kolster J., Uryash A., Esteve E., Altamirano F., Adams J. A. (2018). Dysregulation of intracellular Ca2+ in dystrophic cortical and hippocampal neurons. Mol. Neurobiol. 55 603–618. 10.1007/s12035-016-0311-7 [DOI] [PubMed] [Google Scholar]
- Lopez J. R., Kolster J., Zhang R., Adams J. (2017). Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency. J. Mol. Cell. Cardiol. 108 149–157. 10.1016/j.yjmcc.2017.06.004 [DOI] [PubMed] [Google Scholar]
- Maier T., Follmann M., Hessler G., Kleemann H. W., Hachtel S., Fuchs B., et al. (2015). Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels. Br. J. Pharmacol. 172 3650–3660. 10.1111/bph.13151 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mandegar M., Remillard C. V., Yuan J. X. (2002). Ion channels in pulmonary arterial hypertension. Prog. Cardiovasc. Dis. 45 81–114. [DOI] [PubMed] [Google Scholar]
- Mederos Y., Schnitzler M., Storch U., Meibers S., Nurwakagari P., Breit A., et al. (2008). Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J. 27 3092–3103. 10.1038/emboj.2008.233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mederos Y. S. M., Storch U., Gudermann T. (2016). Mechanosensitive Gq/11 protein-coupled receptors mediate myogenic vasoconstriction. Microcirculation 23 621–625. 10.1111/micc.12293 [DOI] [PubMed] [Google Scholar]
- Miike T., Sugino S., Ohtani Y., Taku K., Yoshioka K. (1987). Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage. J. Neurol. Sci. 82 67–80. 10.1016/0022-510x(87)90007-4 [DOI] [PubMed] [Google Scholar]
- Mijares A., Altamirano F., Kolster J., Adams J. A., Lopez J. R. (2014). Age-dependent changes in diastolic Ca(2+) and Na(+) concentrations in dystrophic cardiomyopathy: role of Ca(2+) entry and IP3. Biochem. Biophys. Res. Commun. 452 1054–1059. 10.1016/j.bbrc.2014.09.045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mule F., D’angelo S., Tabacchi G., Amato A., Serio R. (1999). Mechanical activity of small and large intestine in normal and mdx mice: a comparative analysis. Neurogastroenterol. Motil. 11 133–139. 10.1046/j.1365-2982.1999.00142.x [DOI] [PubMed] [Google Scholar]
- Mule F., Serio R. (2001). Increased calcium influx is responsible for the sustained mechanical tone in colon from dystrophic (mdx) mice. Gastroenterology 120 1430–1437. 10.1053/gast.2001.24054 [DOI] [PubMed] [Google Scholar]
- Murase K., Naruse K., Kimura A., Okumura K., Hayakawa T., Sokabe M. (2001). Protamine augments stretch induced calcium increase in vascular endothelium. Br. J. Pharmacol. 134 1403–1410. 10.1038/sj.bjp.0704386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicotera P., Orrenius S. (1998). The role of calcium in apoptosis. Cell Calcium 23 173–180. 10.1016/s0143-4160(98)90116-6 [DOI] [PubMed] [Google Scholar]
- Nigro G., Comi L. I., Politano L., Bain R. J. (1990). The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26 271–277. 10.1016/0167-5273(90)90082-g [DOI] [PubMed] [Google Scholar]
- North A. J., Galazkiewicz B., Byers T. J., Glenney J. R., Jr., Small J. V. (1993). Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J. Cell Biol. 120 1159–1167. 10.1083/jcb.120.5.1159 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nowak T. V., Ionasescu V., Anuras S. (1982). Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology 82 800–810. 10.1016/0016-5085(82)90330-4 [DOI] [PubMed] [Google Scholar]
- Park K. S., Kim Y., Lee Y. H., Earm Y. E., Ho W. K. (2003). Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ. Res. 93 557–564. 10.1161/01.res.0000093204.25499.83 [DOI] [PubMed] [Google Scholar]
- Petrof B. J., Shrager J. B., Stedman H. H., Kelly A. M., Sweeney H. L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 90 3710–3714. 10.1073/pnas.90.8.3710 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ray J. L., Leach R., Herbert J. M., Benson M. (2001). Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23 185–188. [DOI] [PubMed] [Google Scholar]
- Sharma P., Tran T., Stelmack G. L., Mcneill K., Gosens R., Mutawe M. M., et al. (2008). Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation. Am. J. Physiol. Lung Cell. Mol. Physiol. 294 L57–L68. [DOI] [PubMed] [Google Scholar]
- Spassova M. A., Hewavitharana T., Xu W., Soboloff J., Gill D. L. (2006). A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc. Natl. Acad. Sci. U.S.A. 103 16586–16591. 10.1073/pnas.0606894103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun Z. (2015). Aging, arterial stiffness, and hypertension. Hypertension 65 252–256. 10.1161/hypertensionaha.114.03617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takahashi K., Kakimoto Y., Toda K., Naruse K. (2013). Mechanobiology in cardiac physiology and diseases. J. Cell. Mol. Med. 17 225–232. 10.1111/jcmm.12027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner P. R., Westwood T., Regen C. M., Steinhardt R. A. (1988). Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335 735–738. 10.1038/335735a0 [DOI] [PubMed] [Google Scholar]
- Uryash A., Bassuk J., Kurlansky P., Altamirano F., Lopez J. R., Adams J. A. (2015). Antioxidant properties of whole body periodic acceleration (pGz). PLoS One 10:e0131392. 10.1371/journal.pone.0131392 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waite A., Brown S. C., Blake D. J. (2012). The dystrophin-glycoprotein complex in brain development and disease. Trends Neurosci. 35 487–496. 10.1016/j.tins.2012.04.004 [DOI] [PubMed] [Google Scholar]
- Yip H., Chen W. Y., Leung P. C., Kwan H. Y., Liu C., Huang Y., et al. (2004). Expression of TRPC homologs in endothelial cells and smooth muscle layers of human arteries. Histochem. Cell Biol. 122 553–561. 10.1007/s00418-004-0720-y [DOI] [PubMed] [Google Scholar]
- Yotsukura M., Miyagawa M., Tsuya T., Ishihara T., Ishikawa K. (1988). Pulmonary hypertension in progressive muscular dystrophy of the Duchenne type. Jpn. Circ. J. 52 321–326. 10.1253/jcj.52.321 [DOI] [PubMed] [Google Scholar]
- Yu Y., Fantozzi I., Remillard C. V., Landsberg J. W., Kunichika N., Platoshyn O., et al. (2004). Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc. Natl. Acad. Sci. U.S.A. 101 13861–13866. 10.1073/pnas.0405908101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zou H., Lifshitz L. M., Tuft R. A., Fogarty K. E., Singer J. J. (2002). Visualization of Ca2 + entry through single stretch-activated cation channels. Proc. Natl. Acad. Sci. U.S.A. 99 6404–6409. 10.1073/pnas.092654999 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.